Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Samsung Biologics Reports Third Quarter 2021 Financial Results 2021-10-26 15:23
Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818 2021-10-26 07:30
SCN9A Antisense Pain Killer OLP-1002 Moves into Phase 2a Stage 2021-10-25 20:30
Happiness Biotech Acquires Majority Ownership in Fujian Shennong 2021-10-25 20:00
Meet the Next Resolution in Medicine -- Polaris Biology Releases Starion™, the next-generation mass cytometer 2021-10-23 15:05
2021 Bio-enzyme Application Explorer Summit held in Chengdu 2021-10-22 14:23
Specialised Therapeutics Enters into a New Supply and Distribution Agreement with Incyte to Launch Two New Cancer Therapies, Tafasitamab and Pemigatinib, in Australia, New Zealand and Singapore 2021-10-22 09:00
Luoxin Pharmaceutical signs licensing agreement with Austria-based Marinomed Biotech AG for Budesolv® Budesonide Nasal Spray 2021-10-21 15:58
GenFleet Announces First Patient Dosed in Phase Ib/II Trial of TGF-β R1 Inhibitor in Combination with PD-1 Inhibitor in Global Multi-center Research 2021-10-21 08:05
Bridge Biotherapeutics Announces Initiation of the Phase I Clinical Trial for BBT-401 in China 2021-10-20 07:00
Alterity Therapeutics Announces Expanded ATH434 Phase 2 Clinical Development Program 2021-10-20 05:08
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody 2021-10-19 20:00
Harbour BioMed Announces Dosing of First Patient of Batoclimab Phase II Trial in Patients with Thyroid Eye Disease 2021-10-19 17:52
FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick 2021-10-19 15:01
Farmmi Healthcare Subsidiary Receives BRC and HACCP Certifications 2021-10-18 20:00
I-Mab Announces IND Approval for Phase 2 Clinical Trial of Efineptakin Alfa in Combination with PD-1 Therapy in China 2021-10-18 20:00
WuXi ATU Opens New Manufacturing Facility to Further Enhance Its CTDMO Services for Global Customers 2021-10-18 11:05
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform 2021-10-15 20:50
GV20 Oncotherapy Completes Series B Financing to Advance Pipeline into the Clinic and Expand Immuno-Oncology Drug Discovery Platform 2021-10-14 23:55
BioAgilytix Closes Acquisition of Australia-based 360biolabs® 2021-10-14 19:00
1 79 80 81 82 83 204